Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RICIX vs. IEFA: which is better?

Bottom line

RICIX vs IEFA: the short answer

RICIX (T. Rowe Price International Disciplined Equity Fund) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds.

IEFA is cheaper at 0.07% vs 0.68% — a difference of $61 a year per $10,000 invested.

Over five years, IEFA returned +4.5% a year vs +3.3% for RICIX.

Updated Nov 19, 2026

RICIX vs IEFA side by side

RICIXIEFA
TypeMutual fundETF
Fund familyT. Rowe PriceiShares
CategoryInternational StockInternational Stock
Expense ratio0.68%0.07%
Annual cost per $10k$68$7
10-yr cost on $10k (prospectus)$935$90
Max front load—None
12b-1 fee—0%
1-yr return+1.8%+3.4%
5-yr return (annualized)+3.3%+4.5%
10-yr return (annualized)—+5.4%
Best quarter+16.8%+18.0%
Worst quarter−21.9%−23.5%
Net assets (fund)—$190.1B
Number of holdings—2,632
Portfolio turnover96%3%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

RICIX and IEFA share none of their top holdings.

RICIX top 10

    IEFA top 10

    1. ASML Holding N.V. — 2.50%
    2. Hsbc Holdings Plc — 1.42%
    3. Roche Holding AG — 1.20%
    4. Novartis AG — 1.12%
    5. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
    6. Nestle S.A. — 1.00%
    7. Astrazeneca Plc — 1.00%
    8. Shell Plc — 1.00%
    9. Siemens Aktiengesellschaft — 0.95%
    10. Mitsubishi UFJ Financial Group, Inc. — 0.93%

    FAQ

    What is the difference between RICIX and IEFA?
    RICIX (T. Rowe Price International Disciplined Equity Fund) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds. IEFA is cheaper at 0.07% vs 0.68% — a difference of $61 a year per $10,000 invested.
    Which is cheaper, RICIX or IEFA?
    IEFA has the lower expense ratio (0.07%).
    Should I own both RICIX and IEFA?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.